Chilton Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-53,769
Closed -$7.87M 195
2019
Q1
$7.87M Buy
53,769
+35,809
+199% +$5.19M 0.7% 65
2018
Q4
$2.4M Sell
17,960
-36,715
-67% -$6.02M 0.23% 88
2018
Q3
$10.4M Buy
54,675
+889
+2% +$163K 0.86% 53
2018
Q2
$8.97M Buy
53,786
+7,646
+17% +$1.23M 0.77% 62
2018
Q1
$7.76M Buy
46,140
+3,188
+7% +$535K 0.7% 66
2017
Q4
$7.03M Sell
42,952
-4,660
-10% -$836K 0.64% 69
2017
Q3
$9.76M Sell
47,612
-267
-0.6% -$62.1K 0.94% 51
2017
Q2
$11.6M Buy
47,879
+34,684
+263% +$8.15M 1.28% 27
2017
Q1
$3.15M Sell
13,195
-1,219
-8% -$284K 0.31% 77
2016
Q4
$3.03M Sell
14,414
-6,199
-30% -$1.28M 0.32% 76
2016
Q3
$4.75M Sell
20,613
-6,191
-23% -$1.51M 0.48% 69
2016
Q2
$6.19M Buy
26,804
+12,672
+90% +$2.92M 0.6% 65
2016
Q1
$3.79M Sell
14,132
-12,014
-46% -$3.44M 0.38% 78
2015
Q4
$8.17M Buy
26,146
+4,949
+23% +$1.47M 0.86% 44
2015
Q3
$5.76M Buy
+21,197
New +$6.51M 0.59% 67

Other funds holding AGN

Chilton Capital Management's AGN Position: Q2 2019 in Review

Chilton Capital Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 53,769 shares — an estimated $7.87M sold.

Chilton Capital Management first reported a position in AGN in Q3 2015 and held it in 15 quarters. The position peaked at $11.6M in Q2 2017. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Chilton Capital Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Chilton Capital Management sold 53,769 Allergan plc shares in Q2 2019, an estimated $7.87M.
  • Chilton Capital Management first reported a position in Allergan plc in Q3 2015 and held it in 15 quarters.
  • Chilton Capital Management's Allergan plc position peaked at $11.6M in Q2 2017.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Chilton Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.